Skip to main content

Find Clinical Trials

Home
Conditions
HER2-low or HER2-ultralow

Clinical trial condition

HER2-low or HER2-ultralow

Explore clinical trials studying HER2-low or HER2-ultralow. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

HER2-low or HER2-ultralow trial results

Not Yet Recruiting

A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer

NCT07701941

Conditions: Breast Diseases, Breast Neoplasms, HER2-low or HER2-ultralow, +6 more
Locations: Not specified

View Trial Details